Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Argatroban for Preventing Restenosis After Artery Stenting
NCT01163604Phase 4Completed
- Sponsor
- Jinling Hospital
- Start
- Aug 2010
- Primary completion
- Dec 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of argatroban in intracranial artery stenosis (ICAS), extracranial artery stenosis (ECAS), sponsored by Jinling Hospital. Started Aug 2010; status: completed.
02
Drugs
argatroban
03
Conditions
intracranial artery stenosis (ICAS)extracranial artery stenosis (ECAS)
Beyond the preview
Go deeper on NCT01163604.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01163604.